Moderna, Inc a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request for emergency use authorization (EUA) for its COVID-19 vaccine (mRNA-1273) in children 6 months to under 2 years and 2 years to under 6 years of age to the U.S. Food and Drug Administration and that similar requests are underway with international regulatory authorities. The requests are based on a 25 μg two-dose primary series of mRNA-1273.
- Read more about Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/moderna-files-for-authorization-of-its-covid-19-vaccine-in-young-children-six-months-to-under-six-years-of-age
No comments:
Post a Comment